• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    NUTEX HEALTH ANNOUNCES THE APPOINTMENT OF JOSHUA DETILLIO AS ITS NEW CHIEF OPERATING OFFICER

    9/5/23 5:30:00 AM ET
    $NUTX
    Real Estate
    Real Estate
    Get the next $NUTX alert in real time by email

    HOUSTON, Sept. 5, 2023 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 22 state-of-the-art micro hospitals in 8 states and primary care-centric, risk-bearing physician networks, today announced the appointment of Joshua DeTillio as the Company's Chief Operating Officer effective on or about October 2, 2023.

    Mr. DeTillio is an experienced healthcare leader with over 20 years of hospital experience and 12 years as a CEO in investor-owned, publicly traded companies. He has demonstrated success in collaborating with and leading boards and physicians to drive growth, improve culture, and deliver results on stated metrics in highly competitive markets.

    Among his many successes, Mr. DeTillio most recently served as Chief Executive Officer at Bravera Health, owned by Community Health Systems, where he recruited several new physicians to the Medical Group, including three General Surgeons, a Vascular Surgeon, three in-market Orthopedic Surgeons, and four primary care providers. He contributed to overall market share growth of 4.3% from 2021 to 2022 as a result of ED, EMS, surgical, and service line growth.

    From 2018-2021 Mr. DeTillio served as Chief Executive Officer at Palms West Hospital and The Children's Hospital at Palms West, HCA, where he helped drive significant volume growth from 2018 to 2020 (Robotic Surgery - 25.8%, Deliveries – 10.2%, NICU – 26.8%). In his time there from 2019 to 2020, the EBITDA adjusted growth was 10.7%, with a margin increase from 19.9% to 22.4%, as well as being 12.4% ahead of budget on the 2021 EBITDA.

    Prior to 2018, Mr. DeTillio served as the CAO at Gulf Coast Medical Center where he led a team of 3,588 employees, 710 physicians, and over 600 volunteers, with an annual budget of over $600M. Other accomplishments include serving as the COO at St. Mary's Medical Center and Palm Beach Children's Hospital, COO at North Shore Medical Center, Associate Administrator at Aventura Hospital and Medical Center, Administrative Fellow at Cedars Medical Center, and a Field Artillery Officer in the United States Army.

    Mr. DeTillio holds a BS from the Unites States Military Academy at West Point, an MBA from Vanderbilt University, Owen Graduate School of Management, and a Master of Public Health from Harvard University, Harvard Chan School of Public Health.

    "Nutex has accomplished so much to date and has a very bright future ahead with the disruption and changing marketplace in healthcare. I'm looking forward to being a part of the journey and to add value along the way," stated Josh DeTillio, FACHE, MBA, Chief Operating Officer of Nutex Health.

    "On behalf of the Board and the entire team, it is with great pleasure that we announce the appointment of our new Chief Operating Officer, Josh DeTillio, who brings a wealth of experience in driving revenue growth and operational efficiency to the Company," stated Tom Vo, M.D., MBA, Chairman and Chief Executive Officer of Nutex Health.

    "Josh is an exceptional business leader and has demonstrated the ability to grow and manage hospital systems, develop talented leaders and help hospitals transform, all while delivering strong financial results.  We look forward to working with him on driving efficient and profitable growth for many years to come," stated Warren Hosseinion, M.D., President of Nutex Health.

    About Nutex Health Inc.

    Headquartered in Houston, Texas and founded in 2011, Nutex Health Inc. (NASDAQ:NUTX) is a healthcare management and operations company with two divisions: a Hospital Division and a Population Health Management Division.

    The Hospital Division owns, develops and operates innovative health care models, including micro-hospitals, specialty hospitals, and hospital outpatient departments (HOPDs). This division owns and operates 22 facilities in 8 states.

    The Population Health Management division owns and operates provider networks such as Independent Physician Associations (IPAs). Through our Management Services Organization (MSO), we provide management, administrative and other support services to our affiliated hospitals and physician groups. Our cloud-based proprietary technology platform aggregates clinical and claims data across multiple settings, information systems and sources to create a holistic view of patients and providers, allowing us to deliver greater quality care more efficiently.

    Forward-Looking Statements

    Certain statements and information included in this press release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Act of 1995. When used in this press release, the words or phrases "will", "will likely result," "expected to," "will continue," "anticipated," "estimate," "projected," "intend," "goal," or similar expressions are intended to identify "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks, known and unknown, and uncertainties, many of which are beyond the control of the Company. Such uncertainties and risks include, but are not limited to, our ability to successfully execute our growth strategy, changes in laws or regulations, including the interim final and final rules implemented under the No Surprises Act , economic conditions, dependence on management, dilution to stockholders, lack of capital, the effects of rapid growth upon the Company and the ability of management to effectively respond to the growth and demand for products and services of the Company, newly developing technologies, the Company's ability to compete, conflicts of interest in related party transactions, regulatory matters, protection of technology, lack of industry standards, the effects of competition and the ability of the Company to obtain future financing. An extensive list of factors that can affect future results are discussed in the Current Report on Form 10-Q for the period ended March 31, 2023 under the heading "Risk Factors" in Part I, Item IA thereof, and other documents filed from time to time with the Securities and Exchange Commission. Such factors could materially adversely affect the Company's financial performance and could cause the Company's actual results for future periods to differ materially from any opinions or statements expressed within this press release.

     

    Cision View original content:https://www.prnewswire.com/news-releases/nutex-health-announces-the-appointment-of-joshua-detillio-as-its-new-chief-operating-officer-301917382.html

    SOURCE Nutex Health, Inc.

    Get the next $NUTX alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $NUTX

    DatePrice TargetRatingAnalyst
    11/12/2024$45.00 → $50.00Buy
    Maxim Group
    9/18/2024$45.00Buy
    Maxim Group
    2/22/2023$3.00Outperform
    Northland Capital
    More analyst ratings

    $NUTX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Maxim Group reiterated coverage on Nutex Health with a new price target

    Maxim Group reiterated coverage of Nutex Health with a rating of Buy and set a new price target of $50.00 from $45.00 previously

    11/12/24 8:15:57 AM ET
    $NUTX
    Real Estate

    Maxim Group initiated coverage on Nutex Health with a new price target

    Maxim Group initiated coverage of Nutex Health with a rating of Buy and set a new price target of $45.00

    9/18/24 8:12:45 AM ET
    $NUTX
    Real Estate

    Northland Capital initiated coverage on Nutex Health with a new price target

    Northland Capital initiated coverage of Nutex Health with a rating of Outperform and set a new price target of $3.00

    2/22/23 9:08:40 AM ET
    $NUTX
    Real Estate

    $NUTX
    SEC Filings

    View All

    Nutex Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Nutex Health, Inc. (0001479681) (Filer)

    8/14/25 4:56:03 PM ET
    $NUTX
    Real Estate

    SEC Form NT 10-Q filed by Nutex Health Inc.

    NT 10-Q - Nutex Health, Inc. (0001479681) (Filer)

    8/14/25 4:55:22 PM ET
    $NUTX
    Real Estate

    Nutex Health Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - Nutex Health, Inc. (0001479681) (Filer)

    7/16/25 9:52:37 AM ET
    $NUTX
    Real Estate

    $NUTX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    NUTEX HEALTH PROVIDES FINANCIAL REPORTING UPDATE

    HOUSTON, Aug. 20, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro hospitals and hospital outpatient departments in 11 states and primary care-centric, risk-bearing physician networks, today disclosed non-reliance on its (i) unaudited condensed consolidated financial statements as of and for the three months ended March 31, 2025 contained in the Form 10-Q for the period ended March 31, 2025 (the "Original Form 10-Q") and its (ii) audited consolidated financial statements as of and for the years ended December 31, 2024 and 2023 contained in the Form 10-K for the

    8/20/25 6:51:00 PM ET
    $NUTX
    Real Estate

    NUTEX HEALTH PROVIDES PRELIMINARY SECOND QUARTER FINANCIAL RESULTS, ANNOUNCES DELAY IN FILING ITS 2025 SECOND QUARTER FINANCIAL STATEMENTS AND ANNOUNCES A STOCK REPURCHASE PROGRAM OF UP TO $25 MILLION

    HOUSTON, Aug. 14, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro hospitals and hospital outpatient departments in 11 states and primary care-centric, risk-bearing physician networks, today announced that it will delay filing its Form 10-Q for the period ending June 30, 2025 due to non-cash accounting adjustments related to the treatment of stock based compensation obligations for certain under-construction and ramping hospitals, as disclosed in previous filings. The Company additionally provided preliminary financial results for the three and six months ended

    8/14/25 5:10:00 PM ET
    $NUTX
    Real Estate

    Nutex Health Schedules 2025 Second Quarter Financial Results Release and Conference Call

    HOUSTON, Aug. 8, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro hospitals in 11 states and primary care-centric, risk-bearing physician networks, today announced that it will release financial results for the second quarter ended June 30, 2025 after the close of the stock market on Thursday, August 14, 2025. The Company will discuss those results on a conference call on Friday, August 15, 2025, at 10:30 a.m. ET. Participant Listening: 1-877-407-9208 or 1-201-493-6784 Participant Link: https://callme.viavid.com/viavid/?callme=true&passcode=13746493&h=true&inf

    8/8/25 8:49:00 AM ET
    $NUTX
    Real Estate

    $NUTX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    $NUTX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Jaumot Frank E

    3 - Nutex Health, Inc. (0001479681) (Issuer)

    8/4/25 2:58:17 PM ET
    $NUTX
    Real Estate

    Chief Financial Officer Bates Jon Christian converted options into 1,611 shares and bought $81,810 worth of shares (1,000 units at $81.81), increasing direct ownership by 115% to 4,888 units (SEC Form 4)

    4 - Nutex Health, Inc. (0001479681) (Issuer)

    4/14/25 4:30:48 PM ET
    $NUTX
    Real Estate

    Director Spears Kelvin converted options into 143 shares and covered exercise/tax liability with 34 shares, increasing direct ownership by 0.34% to 31,992 units (SEC Form 4)

    4 - Nutex Health, Inc. (0001479681) (Issuer)

    4/14/25 4:15:36 PM ET
    $NUTX
    Real Estate

    Chief Financial Officer Bates Jon Christian converted options into 1,611 shares and bought $81,810 worth of shares (1,000 units at $81.81), increasing direct ownership by 115% to 4,888 units (SEC Form 4)

    4 - Nutex Health, Inc. (0001479681) (Issuer)

    4/14/25 4:30:48 PM ET
    $NUTX
    Real Estate

    Chief Financial Officer Bates Jon Christian bought $28,970 worth of shares (1,350 units at $21.46), increasing direct ownership by 146% to 2,277 units (SEC Form 4)

    4 - Nutex Health, Inc. (0001479681) (Issuer)

    8/26/24 11:54:30 AM ET
    $NUTX
    Real Estate

    Chief Operating Officer Detillio Joshua bought $10,800 worth of shares (20,000 units at $0.54), increasing direct ownership by 214% to 29,333 units (SEC Form 4)

    4 - Nutex Health, Inc. (0001479681) (Issuer)

    6/13/24 11:50:03 AM ET
    $NUTX
    Real Estate

    $NUTX
    Leadership Updates

    Live Leadership Updates

    View All

    NUTEX HEALTH ANNOUNCES THE APPOINTMENT OF GRANT THORNTON LLP AS ITS INDEPENDENT AUDITOR

    HOUSTON, May 22, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro hospitals and hospital outpatient departments (HOPDs) in 11 states and primary care-centric, risk-bearing physician networks, today announced the appointment of Grant Thornton LLP ("Grant Thornton") as the Company's independent registered public accounting firm to replace CBIZ CPAs ("CBIZ"), effective May 15, 2025. The change of the Company's independent auditor was made after careful consideration and an evaluation process and was approved by the Audit Committee and the Board of Directors of the

    5/22/25 6:30:00 AM ET
    $NUTX
    Real Estate

    NUTEX HEALTH ANNOUNCES CHANGES TO ITS BOARD OF DIRECTORS

    HOUSTON, April 22, 2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals in 9 states and primary care-centric, risk-bearing physician networks, today announced the appointment of Scott J. Saunders, and Kelvin Spears, MD, to its Board of Directors.  They replace John Waters, who recently passed away, and Dr. Daniel Stites, who fulfilled his one-year term Board commitment. The Board has determined that Mr. Saunders satisfies the current independent director standards established by the rules of The Nasdaq Stock Market. Mr. Saunders will s

    4/22/24 5:30:00 AM ET
    $NUTX
    Real Estate

    NUTEX HEALTH ANNOUNCES THE APPOINTMENT OF JOSHUA DETILLIO AS ITS NEW CHIEF OPERATING OFFICER

    HOUSTON, Sept. 5, 2023 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 22 state-of-the-art micro hospitals in 8 states and primary care-centric, risk-bearing physician networks, today announced the appointment of Joshua DeTillio as the Company's Chief Operating Officer effective on or about October 2, 2023. Mr. DeTillio is an experienced healthcare leader with over 20 years of hospital experience and 12 years as a CEO in investor-owned, publicly traded companies. He has demonstrated success in collaborating with and leading boards and physicians to drive growth, improve c

    9/5/23 5:30:00 AM ET
    $NUTX
    Real Estate

    $NUTX
    Financials

    Live finance-specific insights

    View All

    NUTEX HEALTH PROVIDES FINANCIAL REPORTING UPDATE

    HOUSTON, Aug. 20, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro hospitals and hospital outpatient departments in 11 states and primary care-centric, risk-bearing physician networks, today disclosed non-reliance on its (i) unaudited condensed consolidated financial statements as of and for the three months ended March 31, 2025 contained in the Form 10-Q for the period ended March 31, 2025 (the "Original Form 10-Q") and its (ii) audited consolidated financial statements as of and for the years ended December 31, 2024 and 2023 contained in the Form 10-K for the

    8/20/25 6:51:00 PM ET
    $NUTX
    Real Estate

    NUTEX HEALTH PROVIDES PRELIMINARY SECOND QUARTER FINANCIAL RESULTS, ANNOUNCES DELAY IN FILING ITS 2025 SECOND QUARTER FINANCIAL STATEMENTS AND ANNOUNCES A STOCK REPURCHASE PROGRAM OF UP TO $25 MILLION

    HOUSTON, Aug. 14, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro hospitals and hospital outpatient departments in 11 states and primary care-centric, risk-bearing physician networks, today announced that it will delay filing its Form 10-Q for the period ending June 30, 2025 due to non-cash accounting adjustments related to the treatment of stock based compensation obligations for certain under-construction and ramping hospitals, as disclosed in previous filings. The Company additionally provided preliminary financial results for the three and six months ended

    8/14/25 5:10:00 PM ET
    $NUTX
    Real Estate

    Nutex Health Schedules 2025 Second Quarter Financial Results Release and Conference Call

    HOUSTON, Aug. 8, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ:NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro hospitals in 11 states and primary care-centric, risk-bearing physician networks, today announced that it will release financial results for the second quarter ended June 30, 2025 after the close of the stock market on Thursday, August 14, 2025. The Company will discuss those results on a conference call on Friday, August 15, 2025, at 10:30 a.m. ET. Participant Listening: 1-877-407-9208 or 1-201-493-6784 Participant Link: https://callme.viavid.com/viavid/?callme=true&passcode=13746493&h=true&inf

    8/8/25 8:49:00 AM ET
    $NUTX
    Real Estate

    $NUTX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Nutex Health Inc.

    SC 13G - Nutex Health, Inc. (0001479681) (Subject)

    11/14/24 11:02:17 AM ET
    $NUTX
    Real Estate

    SEC Form SC 13G/A filed by Nutex Health Inc. (Amendment)

    SC 13G/A - Nutex Health, Inc. (0001479681) (Subject)

    9/26/23 4:26:07 PM ET
    $NUTX
    Real Estate

    SEC Form SC 13G filed by Nutex Health Inc.

    SC 13G - Nutex Health, Inc. (0001479681) (Subject)

    7/7/23 5:03:39 PM ET
    $NUTX
    Real Estate